Emily Gottschalk - 10 Mar 2022 Form 4 Insider Report for Anixa Biosciences Inc (ANIX)

Role
Director
Signature
/s/ Emily Gottschalk
Issuer symbol
ANIX
Transactions as of
10 Mar 2022
Net transactions value
$0
Form type
4
Filing time
11 Mar 2022, 15:15:33 UTC
Previous filing
16 Jul 2021
Next filing
04 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANIX Employee Stock Option (Right to Buy) Award $0 +100,000 $0.000000 100,000 10 Mar 2022 Common Stock 100,000 $2.74 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Right-To-Buy, granted under the Anixa Biosciences, Inc. 2018 Share Incentive Plan.
F2 The options vest and become exercisable in twelve (12) equal monthly installments beginning March 31, 2022.